Loading
A phase 2 trial of QL1706 and cAPOX (capecitabine, oxaliplatin) in colorectal cancer, run by Qilu Hospital of Shandong University, not yet recruiting.
QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer is a phase 2, interventional study registered as NCT07156682 by Qilu Hospital of Shandong University, with a registry enrolment figure of 21 participants, started 2025-09-25 and due to reach its primary completion in 2027-06-30. Interventions recorded: QL1706; XELOX. Conditions listed: Colon Cancer; MSS/pMMR; QL1706. Primary outcome: Pathological Complete Response (pCR). Colorectal eligibility wording from the registry: "* Histologically or clinically confirmed initially resectable Stage III colon cancer according to the AJCC 8th edition". Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares QL1706, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares QL1706, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag colorectal-deep-dive.
Shares QL1706, Platinum agents, Colorectal cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/